Oral Solid Dosage Contract Manufacturing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theOral Solid Dosage Contract Manufacturing Market?
The oral solid dosage contract manufacturing market is experiencing growth due to increased demand for generic drugs. These medications are bioequivalent to branded ones and are gaining traction due to patent expirations, cost-effectiveness, regulatory incentives, and broader healthcare access. Contract manufacturing aids generic drug production through operational efficiency and quality assurance. In 2022, the U.S. FDA reported that 91% of prescriptions were filled with generics, with over 32,000 approvals granted.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp
#What Growth Opportunities Will Drive the Oral Solid Dosage Contract Manufacturing Market’s CAGR Through 2034?
The oral solid dosage contract manufacturing market grew strongly, rising from $39.39 billion in 2024 to $42.51 billion in 2025 at a CAGR of 7.9%. Growth was fueled by global population growth, chronic disease prevalence, and a stronger focus on R&D.
The oral solid dosage contract manufacturing market is expected to reach $56.89 billion in 2029, at a CAGR of 7.6%. Growth is driven by increased outsourcing in the pharmaceutical industry, advancements in drug delivery, and growing drug development activities. Trends include advancements in drug delivery, integration of 3D printing, and controlled-release technologies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137
Which Upcoming Market Trends and Innovations Are Set to Influence theOral Solid Dosage Contract Manufacturing Market’s Path Forward?
Major companies in the oral solid dosage contract manufacturing market are concentrating on creating innovative solutions, such as continuous manufacturing lines, to maintain their market leadership. A continuous manufacturing line refers to a system that employs continuous manufacturing processes to produce pharmaceutical products. For example, WuXi STA, a China-based pharmaceutical company, launched its first continuous manufacturing line for oral solid pharmaceutical products in January 2023. This state-of-the-art facility represents a significant breakthrough in pharmaceutical production, utilizing continuous manufacturing to improve efficiency, quality, and flexibility. It also reduces production downtime and accelerates the delivery of essential medications.
Who Are the Dominant Market Players Pushing the Boundaries of theOral Solid Dosage Contract Manufacturing Market?
Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Oral Solid Dosage Contract Manufacturing Market, and How Do They Contribute to Growth?
The oral solid dosage contract manufacturing market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies
Subsegments:
1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets (Enteric, Film Coated), Sustained Or Controlled Release Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules
3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders
4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules
5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp
What Regions Are Dominating the Oral Solid Dosage Contract Manufacturing Market Growth?
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2025, By The Business Research Company:
Electronic Contract Manufacturing and Design Services Global Market Report 2024
Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024
Food Contract Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
